Get started
Omega Therapeutics, Inc.Omega Therapeutics, Inc.Omega Therapeutics, Inc.

Omega Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

OMGA chart


Full chart

OMGA upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪27.68 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.3253 USD
Net income (FY)
‪−97.43 M‬ USD
Revenue (FY)
‪3.09 M‬ USD
Shares float
‪19.33 M‬
Beta (1Y)
1.89

Employees


Employees (FY)
94
Change (1Y)
−23 −19.66%
Revenue / Employee (1Y)
‪32.91 K‬ USD
Net income / Employee (1Y)
‪−1.04 M‬ USD

About Omega Therapeutics, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Kaan Certel
Website
omegatherapeutics.com
Headquarters
Cambridge
Founded
2016
FIGI
BBG00WCNQZN4
Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

OMGA news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of OMGA is 0.4766 USD — it has decreased by −5.00% in the past 24 hours. Watch Omega Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Omega Therapeutics, Inc. stocks are traded under the ticker OMGA.
OMGA stock has fallen by −24.60% compared to the previous week, the month change is a −45.88% fall, over the last year Omega Therapeutics, Inc. has showed a −87.01% decrease.
We've gathered analysts' opinions on Omega Therapeutics, Inc. future price: according to them, OMGA price has a max estimate of 4.00 USD and a min estimate of 4.00 USD. Watch OMGA chart and read a more detailed Omega Therapeutics, Inc. stock forecast: see what analysts think of Omega Therapeutics, Inc. and suggest that you do with its stocks.
OMGA reached its all-time high on Nov 1, 2021 with the price of 31.4100 USD, and its all-time low was 0.5231 USD and was reached on Jan 16, 2025. View more price dynamics on OMGA chart.
See other stocks reaching their highest and lowest prices.
OMGA stock is 6.52% volatile and has beta coefficient of 1.89. Track Omega Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Omega Therapeutics, Inc. there?
Today Omega Therapeutics, Inc. has the market capitalization of ‪26.30 M‬, it has decreased by −27.03% over the last week.
Yes, you can track Omega Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Omega Therapeutics, Inc. is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
OMGA earnings for the last quarter are −0.30 USD per share, whereas the estimation was −0.27 USD resulting in a −13.21% surprise. The estimated earnings for the next quarter are −0.20 USD per share. See more details about Omega Therapeutics, Inc. earnings.
Omega Therapeutics, Inc. revenue for the last quarter amounts to ‪2.61 M‬ USD, despite the estimated figure of ‪700.00 K‬ USD. In the next quarter, revenue is expected to reach ‪1.43 M‬ USD.
OMGA net income for the last quarter is ‪−16.44 M‬ USD, while the quarter before that showed ‪−16.30 M‬ USD of net income which accounts for −0.85% change. Track more Omega Therapeutics, Inc. financial stats to get the full picture.
No, OMGA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 24, 2025, the company has 94.00 employees. See our rating of the largest employees — is Omega Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Omega Therapeutics, Inc. EBITDA is ‪−66.84 M‬ USD, and current EBITDA margin is ‪−3.02 K‬%. See more stats in Omega Therapeutics, Inc. financial statements.
Like other stocks, OMGA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Omega Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Omega Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Omega Therapeutics, Inc. stock shows the sell signal. See more of Omega Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.